The Role of Skin and Gut Microbiome in Atopic Dermatitis
DOI:
https://doi.org/10.66344/jpad.v32i1.1816Abstract
In the last decade, there has been an increase case of atopic dermatitis (AD) worldwide. AD is a type of disease with chronic inflammation of the skin characterized by mild to severe itching, recurrent, and mostly occurred in infancy and childhood. There were some substantial data of patients with AD that have been disturbed and less diverse skin and gut microbes than healthy individuals. In the skin microbiome, AD is known to possess a larger percentage of Staphylococcus aureus (S. aureus) than healthy individuals. In addition, the population of Staphylococcus aureus, Clostridium difficile, and Escherichia coli in the gastrointestinal tract of patients with AD is higher than normal individuals, whereas the population of Bifidobacteria, Bacteroidetes, and Bacteroides are experiencing a decrease. The AD will be prevented or treated if there is a balance in the skin and gut microbiome. It seems to underlie the benefit of probiotic in AD management.
References
1. Reddel S, Del Chierico F, Quagliariello A, et al. Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture. Sci Rep. 2019;9(1):1-10.
2. Rather IA, Bajpai VK, Kumar S, et al. Probiotics and atopic dermatitis: An overview. Front Microbiol. 2016; 7(APR):1-7.
3. Kim J, Kim H. Microbiome of the Skin and Gut in Atopic Dermatitis (AD): Understanding the Pathophysiology and Finding Novel Management Strategies. J Clin Med. 2019;8(4):444.
4. Wollina U. Microbiome in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:51-6.
5. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: Impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol. 2004;5(4):217-23.
6. Sudarmono PP. Mikrobioma: pemahaman baru tentang peran mikroorganisme dalam kehidupan manusia. eJournal Kedokt Indones. 2016;4(2):71-5.
7. Hasibuan FEB, Kolondam BJ. Interaction Between Gut Microbiota and the Human Immune System. J Ilm Sains. 2017; 17(1):35-42.
8. Herwanto N, Hutomo M. Studi retrospektif : penatalaksanaan dermatitis atopik (Retrospective study : management of atopic dermatitis). Penatalaksanaan Dermat Atopik. 2016;28(1):8-17.
9. Patel N, Feldman SR. Management of atopic dermatitis. Adherence in atopic Dermatitis. Introduction. Adv Exp Med Biol. 2017; 1027:139-59.
10. Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep. 2015;15(11).65.
11. Lee SY, Lee E, Park YM, Hong SJ. Microbiome in the gut-skin axis in atopic dermatitis. Allergy Asthma Immunol Res. 2018;10(4):354-62.
12. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40(2):84-92.
13. Pandaleke TA, Pandaleke HEJ. Etiopatogenesis Dermatitis Atopi. J Biomedik. 2014;6(2).
14. Zaniboni MC, Orfali RL, Samorano LP, Aoki V. Skin barrier in atopic dermatitis: beyond filaggrin. An Bras Dermatol. 2016;91(4):472-8.
15. Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(s2):1-10.
16. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850-9.
17. Oh J, Freeman AF, Park M, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res. 2013;23(12):2103-4.
18. Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9(378):1-12.
19. Kurniati AM. Mikrobiota Saluran Cerna : Tinjauan dari Aspek Pemilihan Asupan Makanan - The Gut Microbiota : A Review of Diet Preferences. JK Unila. 2016;1(2):380-4.
20. Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10(1):18-26.
21. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8(3):171-84.
22. Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2003;111(3):587-91.
23. Penders J, Stobberingh EE, Thijs C, et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy. 2006;36(12):1602-8.
24. 24. Penders J, Thijs C, Van Den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: The KOALA birth cohort study. Gut. 2007;56(5):661-7.
25. Nylund L, Nermes M, Isolauri E, et al. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Eur J Allergy Clin Immunol. 2015; 70(2):241-4.
26. Nowrouzian FL, Lina G, Hodille E, et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema. Br J Dermatol. 2017;176(2):439-45.
27. Lee E, Lee SY, Kang MJ, et al. Clostridia in the gut and onset of atopic dermatitis via eosinophilic inflammation. Ann Allergy Asthma Immunol. 2016;117(1):91-92.
28. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, et al. Probiotics for the treatment of eczema: A systematic review. Clin Exp Allergy. 2009;39(8):1117-27.
29. Prakoeswa CRS, Bonita L, Karim A, et al. Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial. J Dermatolog Treat. 2020;0(0):1-8. Available from:
https://doi.org/10.1080/09546634.2020.1836310
30. Prakoeswa CRS, Herwanto N, Prameswari R, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes. 2017;8(5):833-40.
31. Blanchet-Réthoré S, Bourdès V, Mercenier A, et al. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:249-57.
32. Butler É, Lundqvist C, Axelsson J. Lactobacillus reuteri DSM 17938 as a novel topical cosmetic ingredient: A proof of concept clinical study in adults with atopic dermatitis. Microorganisms. 2020;8(7):1-15.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Menul Ayu Umborowati, MD, Nurdini Wilda Salsabila, MD, Damayanti, MD, PhD, Sylvia Anggraeni, MD, Prof. Cita Rosita Sigit Prakoeswa, MD, PhD
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
